The use of a combination of daunorubicin and cytosine arabinoside in the treatment of acute myeloid leukaemia in a district general hospital is described. The results in a series of 30 cases are considered.
No takes yet. Share an insight, caveat, or question.
Friend et al. (1974) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: